Related Experiment Video
Updated: Jun 20, 2025

12:28
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
17.3K
Data-Driven Subtypes of Multiple System Atrophy and Their Implications for Prognosis
Cheng-Cheng Fan1, Chao Han2, Xue-Mei Wang3
1Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Journal of Parkinson'S Disease
|July 20, 2024
Summary
This study identified four distinct clinical profiles in multiple system atrophy (MSA), revealing that malignant diffuse and rigid akinetic subtypes significantly worsen prognosis and increase the risk of becoming bedbound compared to other MSA phenotypes.
Area of Science:
- Neurology
- Clinical Phenotyping
- Disease Progression
Background:
- Multiple system atrophy (MSA) exhibits significant heterogeneity in motor and non-motor symptoms.
- The relationship between distinct clinical phenotypes and patient prognosis in MSA remains poorly understood.
Purpose of the Study:
- To employ a data-driven approach to define clinical phenotypes in MSA.
- To assess the impact of identified MSA phenotypes on patient survival and the likelihood of becoming bedbound.
Main Methods:
- Cluster analysis was used to categorize 193 MSA patients based on their clinical history, motor, and non-motor symptoms.
- Kaplan-Meier analysis, Cox regression, and logistic regression were utilized to evaluate survival and identify factors associated with survival and bedbound status in 95 followed-up patients.
Main Results:
- Four distinct MSA clinical profiles were identified: cerebellar symptom-dominant, sleep and mood disorder-dominant, rigid akinetic-dominant, and malignant diffuse.
- The malignant diffuse and rigid akinetic-dominant clusters demonstrated a significantly higher risk of mortality and becoming bedbound compared to the sleep and mood disorder-dominant and cerebellar symptom-dominant clusters, respectively.
- Median survival for the overall MSA cohort was 7.75 years.
Conclusions:
- Beyond classical parkinsonism and cerebellar subtypes, malignant diffuse and sleep/mood disorder-dominant profiles were identified.
- Patients with rigid-akinetic motor profiles generally face a worse prognosis than those with cerebellar symptom-dominant profiles.
- Early identification of diffuse symptoms, particularly postural instability and cognitive changes, signals rapid functional decline and disease progression, potentially indicating diverse underlying pathologies.
More Related Videos
Related Concept Videos
Parkinson's Disease: Overview
517
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
517
Alzheimer's Disease: Overview
456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456

